Sub-dissociative dose ketamine administration for managing pain in the emergency department

doi:10.5847/wjem.j.1920-8642.2018.04.002

Abstract

Abstract:

BACKGROUND: We describe our experience of utilizing sub-dissociative dose ketamine (SDK) in managing a variety of acute and chronic painful conditions in the emergency department (ED).
METHODS: A descriptive study was conducted in our ED over a period of seven years (2010-2016) by retrospectively reviewing charts of patients aged 18 and older presenting to the ED with painful complaints and receiving SDK analgesia. Primary data analyses included type of SDK administration (intravenous push [IVP], short-infusion [SI] or continuous infusion [CI]), dosing, rates of analgesic utilization before and after SDK administration, and adverse effects.
RESULTS: Three hundred sixty-two patients were enrolled in the study. Mean ketamine doses given by IVP, SI and CI were 26.3 mg, 23.4 mg, and 11.3 mg. The mean duration of CI was 135.87 minutes. The percentage of patients not requiring post-SDK analgesia increased by 16%, 18%, and 37% in IVP, SI and CI groups. Adverse effects were recorded for 13% of patients.
CONCLUSION: SDK administered by IVP, SI, and CI in the ED for a variety of painful conditions is a feasible analgesic modality in the ED that is associated with a decrease in overall requirements of post-ketamine analgesia and opioid sparing.

Key words: Ketamine, Analgesia, Emergency department, Sub-dissociative, Infusion

Sergey Motov, Jefferson Drapkin, Antonios Likourezos, Joshua Doros, Ralph Monfort, John Marshall. Sub-dissociative dose ketamine administration for managing pain in the emergency department[J]. World Journal of Emergency Medicine, 2018, 9(4): 249-255.

Figures/Tables 6

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

References 21

[1]	Gao M, Rejaei D, Liu H. Ketamine use in current clinical practice. Acta Pharmacol Sin. 2016; 37(7):865-72. Epub 2016 Mar 28. doi: 10.1038/aps.2016.5 pmid: 27018176
[2]	Kurdi MS, Theerth KA, Deva RS. Ketamine: Current applications in anesthesia, pain, and critical care. Anesth Essays Res. 2014; 8(3):283-9. pmid: 25886322
[3]	Tziavrangos E, Schug SA. Clinical Pharmacology: other adjuvants. In Macyntyre P, et al. Clinical Pain Management (Acute Pain), pp: 98-101. Second Edition, 2008 Hodder & Stoughton Limited.
[4]	Jennings PA, Cameron P, Bernard S. Ketamine as an analgesic in the pre-hospital setting: a systematic review. Acta Anaesthesiol Scand. 2011; 55(6):638-43. doi: 10.1111/j.1399-6576.2011.02446.x pmid: 21574967
[5]	Ahern TL, Herring AA, Anderson ES, Madia VA, Fahimi J, Frazee BW. The first 500: initial experience with widespread use of low-dose ketamine for acute pain management in the ED. Am J Emerg Med. 2015; 33(2):197-201. pmid: 25488336
[6]	Ahern TL, Herring AA, Miller S, Frazee BW. Low-dose ketamine infusion for emergency department patients with severe pain. Pain Med. 2015; 16(7):1402-9. doi: 10.1111/pme.12705 pmid: 25643741
[7]	Lester L, Braude DA, Niles C, Crandall CS. Low-dose ketamine for analgesia in the ED: a retrospective case series. Am J Emerg Med. 2010; 28(7):820-7. doi: 10.1016/j.ajem.2009.07.023 pmid: 20837262
[8]	Richards JR, Rockford RE. Low-dose ketamine analgesia: patient and physician experience in the ED. Am J Emerg Med. 2013; 31(2):390-4. pmid: 23041484
[9]	Beaudoin FL, Lin C, Guan W, Merchant RC. Low-dose ketamine improves pain relief in patients receiving intravenous opioids for acute pain in the emergency department: results of a randomized, double-blind, clinical trial. Acad Emerg Med. 2014; 21(11):1193-202. doi: 10.1111/acem.12510 pmid: 25377395
[10]	Bowers KJ, McAllister KB, Ray M, Heitz C. Ketamine as an adjunct to opioids for acute pain in the emergency department: a randomized controlled trial. Acad Emerg Med. 2017; 24(6):676-85. doi: 10.1111/acem.13172 pmid: 28177167
[11]	Farnia MR, Babaei R, Shirani F, Momeni M, Hajimaghsoudi M, Vahidi E, et al. Analgesic effect of paracetamol combined with low-dose morphine versus morphine alone on patients with biliary colic: a double blind, randomized controlled trial. World J Emerg Med. 2016; 7(1):25-9. doi: 10.5847/wjem.j.1920-8642.2016.01.004 pmid: 27006734
[12]	Motov S, Rockoff B, Cohen V, Pushkar I, Likourezos A, McKay C, et al. Intravenous subdissociative-dose ketamine versus morphine for analgesia in the emergency department: a randomized controlled trial. Ann Emerg Med. 2015; 66(3):222-9. doi: 10.1016/j.annemergmed.2015.03.004 pmid: 25817884
[13]	Majidinejad S, Esmailian M, Emadi M. Comparison of intravenous ketamine with morphine in pain relief of long bones fractures: a double blind randomized clinical trial. Emerg (Tehran). 2014; 2(2):77-80.
[14]	Goltser A, Soleyman-Zomalan E, Kresch F, Motov S. Short (low-dose) ketamine infusion for managing acute pain in the ED: case-report series. Am J Emerg Med. 2015; 33(4):601.e5-7.
[15]	Motov S, Mai M, Pushkar I, Likourezos A, Drapkin J, Yasavolian M, et al. A prospective randomized, double-dummy trial comparing IV push low dose ketamine to short infusion of low dose ketamine for treatment of pain in the ED. Am J Emerg Med. 2017; 35(8):1095-100. pmid: 28283340
[16]	Sheehy KA, Lippold C, Rice AL, Nobrega R, Finkel JC, Quezado ZM. Subanesthetic ketamine for pain management in hospitalized children, adolescents, and young adults: a single-center cohort study. J Pain Res. 2017; 10:787-95. doi: 10.2147/JPR.S131156 pmid: 28435316
[17]	Zempsky WT, Loiselle KA, Corsi JM, Hagstrom JN. Use of low-dose ketamine infusion for pediatric patients with sickle cell disease-related pain: a case series. Clin J Pain. 2010; 26(2):163-7. doi: 10.1097/AJP.0b013e3181b511ab pmid: 20090444
[18]	Uprety D, Baber A, Foy M. Ketamine infusion for sickle cell pain crisis refractory to opioids: a case report and review of literature. Ann Hematol. 2014; 93(5):769-71. doi: 10.1007/s00277-013-1954-3 pmid: 24232306
[19]	Tawfic QA, Eipe N, Penning J. Ultra-low-dose ketamine infusion for ischemic limb pain. Can J Anaesth. 2014; 61(1):86-7. doi: 10.1007/s12630-013-0050-4 pmid: 24122230
[20]	Motov S, Drapkin J, Likourezos A, Beals T, Monfort R, Fromm C, et al. Continuous intravenous sub-dissociative dose ketamine infusion for managing pain in the emergency department. West J Emerg Med. 2018; 19(3):559-66. doi: 10.5811/westjem.2017.12.36174 pmid: 29760856
[21]	Klaess CC, Jungguist CR. Current Ketamine Practice: Results of the 2016 American Society of Pain Management Nursing Survery on Ketamine. Pain Manag Nurs. 2018; 19(3):222-9. doi: 10.1016/j.pmn.2018.02.063 pmid: 29685736